Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
DOVA PHARMACEUTICALS, INC.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
2016

Previous Name(s)

  • DOVA PHARMACEUTICALS, LLC
  • PBM AKX HOLDINGS, LLC
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

200 GARRETT STREET
SUITE S
CHARLOTTESVILLE, VA 22902
Phone Number: subscription required

Item 3. Related Persons

Name
PAUL B. MANNING
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
JOHN A. STALFORT
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
JAMES C. REEBALS
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
EUGENE R. SCAVOLA
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
DAMIAN DEGOA
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
RUSSELL T. SCHUNDLER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
HOSSEIN EKRAMI
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
PBM CAPITAL INVESTMENTS LLC
Address
subscription required
Relationship(s)
  • PROMOTER
Clarification of Response

Item 3. Related Persons

Name
BKB GROWTH INVESTMENTS, LLC
Address
subscription required
Relationship(s)
  • PROMOTER
Clarification of Response

Item 4. Industry Group

PHARMACEUTICALS

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
09/19/2016

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
2500000

Item 13. Offering and Sales Amounts

Total Offering Amount
40000000
Total Amount Sold
10000000
Total Remaining to be Sold
30000000
Clarification of Response
THE ISSUER'S BOARD MAY HAVE ONE OR MORE CLOSINGS AT ANY TIME AND FROM TIME TO TIME AFTER RECEIVING INVESTMENTS TOTALING $10,000,000. THE ISSUER'S BOARD MAY ALSO ACCEPT LESS THAN THE STATED MINIMUM INVESTMENT AMOUNT OF $2,500,000 IN ITS DISCRETION.

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
0.0 Is an estimate
Finders' Fees
0.0 Is an estimate
Clarification of Response
THE ISSUER MAY IN THE FUTURE RETAIN A BROKER IN CONNECTION WITH THE OFFERING BUT HAS NOT YET DONE SO.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
600000.0 Is an estimate
Clarification of Response

Signature and Submission

Issuer Name
DOVA PHARMACEUTICALS, INC.
Issuer Signature
/RUSSELL T. SCHUNDLER/
Signer Name
RUSSELL T. SCHUNDLER
Signer Title
SECRETARY
Signature Date
09/23/2016
WhaleWisdom Logo

Elevate your investments